Dr. Sise’s complete bibliography is available here.
- Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure
- Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function
- Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study
- Reply to 'Use of convalescent plasma in the treatment of COVID-19'
- Early initiation of glecaprevir/pibrentasvir after transplantation of HCV-viremic kidneys into HCV-negative recipients is associated with normalization in the altered inflammatory milieu
- Author Correction: Therapeutic advances in COVID-19
- Authors' Reply
- Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR
- Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis
- Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma
- Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
- Therapeutic advances in COVID-19
- Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19
- Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI
- Modulation of the Association Between Age and Death by Risk Factor Burden in Critically Ill Patients With COVID-19
- Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer
- Comparison of short- and long-term adverse kidney outcomes after chimeric antigen receptor T cell therapy and autologous hematopoietic stem cell transplant for diffuse large B cell lymphoma
- Immune checkpoint inhibitors and kidney disease
- Onconephrology: The Growth of Cancer-Kidney Connection, Part 2
- Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study
